These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 37031947)

  • 1. Escitalopram's inflammatory effect on the mammalian macrophages and its intracellular mechanism of action.
    Önal HT; Yetkin D; Ayaz F
    Prog Neuropsychopharmacol Biol Psychiatry; 2023 Jul; 125():110762. PubMed ID: 37031947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mechanisms of action of antidepressants: new data from Escitalopram].
    Fabre V; Hamon M
    Encephale; 2003; 29(3 Pt 1):259-65. PubMed ID: 12876551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo investigation of escitalopram's allosteric site on the serotonin transporter.
    Murray KE; Ressler KJ; Owens MJ
    Pharmacol Biochem Behav; 2016 Feb; 141():50-7. PubMed ID: 26621784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 17β-Estradiol augments antidepressant efficacy of escitalopram in ovariectomized rats: Neuroprotective and serotonin reuptake transporter modulatory effects.
    Ibrahim WW; Safar MM; Khattab MM; Agha AM
    Psychoneuroendocrinology; 2016 Dec; 74():240-250. PubMed ID: 27685339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of S-citalopram, citalopram, and R-citalopram on the firing patterns of dopamine neurons in the ventral tegmental area, N-methyl-D-aspartate receptor-mediated transmission in the medial prefrontal cortex and cognitive function in the rat.
    Schilström B; Konradsson-Geuken A; Ivanov V; Gertow J; Feltmann K; Marcus MM; Jardemark K; Svensson TH
    Synapse; 2011 May; 65(5):357-67. PubMed ID: 20730799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Escitalopram and citalopram: the unexpected role of the R-enantiomer].
    Jacquot C; David DJ; Gardier AM; Sánchez C
    Encephale; 2007; 33(2):179-87. PubMed ID: 17675913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Escitalopram: a selective inhibitor and allosteric modulator of the serotonin transporter].
    Mnie-Filali O; El Mansari M; Scarna H; Zimmer L; Sánchez C; Haddjeri N
    Encephale; 2007 Dec; 33(6):965-72. PubMed ID: 18789789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of serotonin transporter expression by escitalopram under inflammation.
    Mena S; Cruikshank A; Best J; Nijhout HF; Reed MC; Hashemi P
    Commun Biol; 2024 Jun; 7(1):710. PubMed ID: 38851804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunostimulatory activity of fluoxetine in macrophages via regulation of the PI3K and P38 signaling pathways.
    Önal HT; Yetkin D; Ayaz F
    Immunol Res; 2023 Jun; 71(3):413-421. PubMed ID: 36512200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biphasic effects of selective serotonin reuptake inhibitors on anxiety: rapid reversal of escitalopram's anxiogenic effects in the novelty-induced hypophagia test in mice?
    Koek W; Mitchell NC; Daws LC
    Behav Pharmacol; 2018 Jun; 29(4):365-369. PubMed ID: 29035921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anxiolytic-like effects of escitalopram, citalopram, and R-citalopram in maternally separated mouse pups.
    Fish EW; Faccidomo S; Gupta S; Miczek KA
    J Pharmacol Exp Ther; 2004 Feb; 308(2):474-80. PubMed ID: 14593091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Mechanism for the Allosteric Inhibition of the Human Serotonin Transporter by Antidepressant Escitalopram.
    Xue W; Fu T; Deng S; Yang F; Yang J; Zhu F
    ACS Chem Neurosci; 2022 Feb; 13(3):340-351. PubMed ID: 35041375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of escitalopram, R-citalopram, and reboxetine on serum levels of tumor necrosis factor-α, interleukin-10, and depression-like behavior in mice after lipopolysaccharide administration.
    Dong C; Zhang JC; Yao W; Ren Q; Yang C; Ma M; Han M; Saito R; Hashimoto K
    Pharmacol Biochem Behav; 2016 May; 144():7-12. PubMed ID: 26892759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Onset of action of escitalopram compared with other antidepressants: results of a pooled analysis.
    Kasper S; Spadone C; Verpillat P; Angst J
    Int Clin Psychopharmacol; 2006 Mar; 21(2):105-10. PubMed ID: 16421462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Escitalopram: a unique mechanism of action.
    Bræstrup C; Sanchez C
    Int J Psychiatry Clin Pract; 2004; 8 Suppl 1():11-3. PubMed ID: 24930683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Escitalopram, the S-(+)-enantiomer of citalopram, is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and anxiolytic activities.
    Sánchez C; Bergqvist PB; Brennum LT; Gupta S; Hogg S; Larsen A; Wiborg O
    Psychopharmacology (Berl); 2003 Jun; 167(4):353-62. PubMed ID: 12719960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective Serotonin Reuptake Inhibitor Use and Risk of Arrhythmia: A Nationwide, Population-Based Cohort Study.
    Lin YT; Lu TS; Hansen RA; Wang CC
    Clin Ther; 2019 Jun; 41(6):1128-1138.e8. PubMed ID: 31178037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic treatment with escitalopram but not R-citalopram translocates Galpha(s) from lipid raft domains and potentiates adenylyl cyclase: a 5-hydroxytryptamine transporter-independent action of this antidepressant compound.
    Zhang L; Rasenick MM
    J Pharmacol Exp Ther; 2010 Mar; 332(3):977-84. PubMed ID: 19996298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor and its targets in the inflammatory cytokine pathway are identified as putative transcriptomic biomarkers for escitalopram response.
    Powell TR; Schalkwyk LC; Heffernan AL; Breen G; Lawrence T; Price T; Farmer AE; Aitchison KJ; Craig IW; Danese A; Lewis C; McGuffin P; Uher R; Tansey KE; D'Souza UM
    Eur Neuropsychopharmacol; 2013 Sep; 23(9):1105-14. PubMed ID: 23142150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Micromolar concentrations of citalopram or escitalopram inhibit glycoprotein VI-mediated and integrin αIIbβ3-mediated signaling in human platelets.
    Tseng YL; Braun A; Chang JP; Chiang ML; Tseng CY; Chen W
    Toxicol Appl Pharmacol; 2019 Feb; 364():106-113. PubMed ID: 30592962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.